UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: September 23, 2025
Accession Number: 0001493152-25-014228
Submission Type: POS AM
CIK: 0001815974
Company Name: Anebulo Pharmaceuticals, Inc.
File Number: 333-268113